| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 10907887 | Experimental Hematology | 2005 | 7 Pages |
Abstract
These data demonstrate that MIP-1α utilizes either CCR1 or CCR5 for its effects on OCL formation and myeloma cells, and that blocking either CCR1 or CCR5 inhibits OCL formation and myeloma cell adhesion to stromal cells.
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Cancer Research
Authors
Yasuo Oba, Jun Won Lee, Lori A. Ehrlich, Ho Yeon Chung, Diane F. Jelinek, Natalie S. Callander, Richard Horuk, Sun Jin Choi, G. David Roodman,